Press conference announcing AstraZeneca’s approval by the Ministry of Health to launch: A new medication for the treatment of hypertension and heart diseases.
The press conference to cover and follow up on the Advanced Course in Sports Emergency Management, sponsored by ParkvilleDecember 7, 2024
The press conference, under the patronage of the National Institute of Diabetes and Endocrinology, to announce the launch of a new medication by Lilly: (Once-Weekly Injection)December 7, 2024